Literature DB >> 9590248

Localization and regulation of IFN-gamma production within the granulomas of murine schistosomiasis in IL-4-deficient and control mice.

E Rakasz1, A M Blum, A Metwali, D E Elliott, J Li, Z K Ballas, K Qadir, R Lynch, J V Weinstock.   

Abstract

Schistosome granulomas from normal or IL-4-deficient C57BL/6 mice make little IFN-gamma and show no Th1 polarization. This could signify that these granulomas have few cells capable of IFN-gamma synthesis or that such cells are under tight control. Granulomas can make IL-10 and TGF-beta, which can regulate IFN-gamma synthesis. Using FACS analysis and ELISA, we explored the origin and regulation of IFN-gamma in schistosome granulomas from both IL-4(-/-) and IL-4(+/+) mice. FACS analysis of intracytoplasmic IFN-gamma staining showed that some granuloma Thy1.2+ T cells (CD8+ and CD4+) express IFN-gamma. Granulomas had NK1.1+ cells, but they appeared to produce little or no IFN-gamma. Purified granuloma Thy1.2+ cells made IFN-gamma in vitro, whereas isolated NK1.1+ lymphocytes secreted little even with rIL-12 stimulation. Culture of granuloma cells with blocking anti-IL-10 or anti-TGF-beta mAb or with rIL-12 substantially increased T cell IFN-gamma synthesis, particularly in the IL-4(-/-) animals. Cultured granuloma cells depleted of Thy1.2+ lymphocytes by Ab and C released no IFN-gamma. It is concluded that granuloma IFN-gamma comes from T cells, not NK cells. Also, this T cell-derived IFN-gamma is subject to IL-10 and TGF-beta regulation, which is particularly evident in IL-4(-/-) mice. Thus, the Th2 granuloma of schistosomiasis has large numbers of activated Th1 or Th0 lymphocytes that are under tight restraint.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9590248

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  Regulation of immunity at tissue sites of inflammation.

Authors:  Dorothy K Sojka; Christopher A Lazarski; Yu-Hui Huang; Irina Bromberg; Angela Hughson; Deborah J Fowell
Journal:  Immunol Res       Date:  2009-01-31       Impact factor: 2.829

Review 2.  Role of helminths in regulating mucosal inflammation.

Authors:  Joel V Weinstock; Robert W Summers; David E Elliott
Journal:  Springer Semin Immunopathol       Date:  2005-06-15

3.  Dexamethasone, a drug for attenuation of Schistosoma mansoni infection morbidity.

Authors:  Alexandre dos Santos Pyrrho; Juliene Antonio Ramos; Roberto Moura Neto; Célia Santos da Silva; Henrique Leonel Lenzi; Christina Maeda Takiya; Cerli Rocha Gattass
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

4.  Role of gamma interferon in the pathogenesis of severe schistosomiasis in interleukin-4-deficient mice.

Authors:  A C La Flamme; E A Patton; E J Pearce
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

Review 5.  Signals for the execution of Th2 effector function.

Authors:  Deborah J Fowell
Journal:  Cytokine       Date:  2009-02-23       Impact factor: 3.861

6.  Interleukin-4 receptor alpha chain and STAT6 signaling inhibit gamma interferon but not Th2 cytokine expression within schistosome granulomas.

Authors:  Ahmed Metwali; Arthur Blum; David E Elliott; Joel V Weinstock
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

7.  Pathogen-imposed skewing of mouse chemokine and cytokine expression at the infected tissue site.

Authors:  Shoshana D Katzman; Deborah J Fowell
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

8.  Chronic schistosome infection leads to modulation of granuloma formation and systemic immune suppression.

Authors:  Steven K Lundy; Nicholas W Lukacs
Journal:  Front Immunol       Date:  2013-02-20       Impact factor: 7.561

Review 9.  Th1/Th2 balance in infection.

Authors:  C Infante-Duarte; T Kamradt
Journal:  Springer Semin Immunopathol       Date:  1999

10.  Follicular helper T cells promote liver pathology in mice during Schistosoma japonicum infection.

Authors:  Xiaojun Chen; Xiaowei Yang; Yong Li; Jifeng Zhu; Sha Zhou; Zhipeng Xu; Lei He; Xue Xue; Weiwei Zhang; Xiaoxiao Dong; Henry Wu; Carrie J Li; Hsiang-Ting Hsu; Wenjun Kong; Feng Liu; Prem B Tripathi; Michelle S Yu; Jason Chang; Liang Zhou; Chuan Su
Journal:  PLoS Pathog       Date:  2014-05-01       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.